Literature DB >> 23331688

In vitro antiseptic susceptibilities for Staphylococcus pseudintermedius isolated from canine superficial pyoderma in Japan.

Nobuo Murayama1, Masahiko Nagata, Yuri Terada, Mio Okuaki, Noriyuki Takemura, Hidemasa Nakaminami, Norihisa Noguchi.   

Abstract

BACKGROUND: Topical therapy, particularly with chlorhexidine, is becoming increasingly common as a treatment option for canine pyoderma; however, there are limited studies on the susceptibility of Staphylococcus pseudintermedius to chlorhexidine compounds.
OBJECTIVES: To determine the in vitro susceptibility of both meticillin-resistant and meticillin-susceptible S. pseudintermedius isolates to chlorhexidine and other antiseptic agents and the presence of multidrug efflux pump genes. SAMPLES: One hundred S. pseudintermedius isolates from 23 initial and 77 recurrent cases of canine pyoderma.
METHODS: After bacterial identification and mecA testing, minimal inhibitory concentrations (MICs) of antiseptic agents were determined. Multidrug efflux pump genes, including qacA, qacB and smr, were identified.
RESULTS: Of the 100 isolates, 57 were identified as meticillin-resistant S. pseudintermedius. The MIC(90) of chlorhexidine acetate, chlorhexidine gluconate, acriflavine, ethidium bromide and benzalkonium chloride were 1, 1, 2, 0.5 and 2 μg/mL, respectively. Multidrug efflux pump genes qacA, qacB and smr were not detected in any of the isolates. CONCLUSIONS AND CLINICAL IMPORTANCE: The MICs for chlorhexidine and other antiseptics remain low, and multidrug efflux pump genes were not found in the tested isolates.
© 2013 The Authors. Veterinary Dermatology © 2013 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23331688     DOI: 10.1111/j.1365-3164.2012.01103.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  6 in total

1.  A case of methicillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma in a Labrador retriever dog.

Authors:  Jennifer Wan
Journal:  Can Vet J       Date:  2014-11       Impact factor: 1.008

2.  Influence of hospital size on antimicrobial resistance and advantages of restricting antimicrobial use based on cumulative antibiograms in dogs with Staphylococcus pseudintermedius infections in Japan.

Authors:  Keita Iyori; Taku Shishikura; Kenta Shimoike; Kenichi Minoshima; Ichiro Imanishi; Yoichi Toyoda
Journal:  Vet Dermatol       Date:  2021-05-19       Impact factor: 1.867

3.  A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius.

Authors:  Des Field; Noémie Gaudin; Francy Lyons; Paula M O'Connor; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  Prevalence of antimicrobial-resistant staphylococci in nares and affected sites of pet dogs with superficial pyoderma.

Authors:  Hidemasa Nakaminami; Yuu Okamura; Satomi Tanaka; Takeaki Wajima; Nobuo Murayama; Norihisa Noguchi
Journal:  J Vet Med Sci       Date:  2020-12-18       Impact factor: 1.267

5.  In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius.

Authors:  Matthew DiCicco; Suresh Neethirajan; J Scott Weese; Ameet Singh
Journal:  BMC Microbiol       Date:  2014-05-19       Impact factor: 3.605

6.  In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms.

Authors:  Des Field; Rory O' Connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Front Microbiol       Date:  2016-04-18       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.